Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended
Dec. 31, 2013
Dec. 31, 2012
REVENUES    
Neurometric Services $ 45,000 $ 28,200
OPERATING EXPENSES:    
Cost of Neurometric Service revenues 37,600 31,400
Research 31,700 55,800
Product development 326,600 87,100
Sales and marketing 91,500 91,500
General and administrative 521,500 461,300
Total operating expenses 1,008,900 727,100
OPERATING LOSS (963,900) (698,900)
OTHER INCOME (EXPENSE):    
Interest income (expense), net (1,000) (598,400)
Gain on extinguishment of debt 1,105,200 466,300
Financing fees 0 (31,700)
Loss on derivative liabilities 0 (97,600)
Total other income (expense) 1,104,200 (261,400)
INCOME(LOSS) BEFORE PROVISION FOR INCOME TAXES 140,300 (960,300)
Provision for income taxes 1,600 800
INCOME(LOSS) FROM CONTINUING OPERATIONS 138,700 (961,100)
Loss from discontinued operations (3,600) (12,200)
NET INCOME (LOSS) $ 135,100 $ (973,300)
BASIC INCOME (LOSS) PER SHARE:    
From continuing operations (in dollars per share) $ 0.00 $ (0.47)
From discontinued operations (in dollars per share) $ 0.00 $ (0.01)
Combined Net Income (Loss) (in dollars per share) $ 0.00 $ (0.48)
DILUTED INCOME (LOSS) PER SHARE:    
From continuing operations (in dollars per share) $ 0.00 $ (0.47)
From discontinued operations (in dollars per share) $ 0.00 $ (0.01)
Combined Net Income (Loss) (in dollars per share) $ 0.00 $ (0.48)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic (in shares) 95,047,482 2,024,619
Diluted (in shares) 107,847,965 2,024,619